Navigation Links
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Date:2/18/2010

rrow cancer.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

Rituxan, an anti-cancer drug, is intended for patients with CLL who are beginning chemotherapy for the first time and for those who have not responded to other cancer drugs for CLL. Rituxan is administered with two other chemotherapy drugs, fludarabine and cyclophosphamide.

CLL primarily affects people older than 50 and arises from a group of white blood cells known as B-cells—part of the body's immune system. Each year, about 16,000 people are diagnosed with and 4,400 die from CLL.

"Rituxan is the third drug approved for the treatment of CLL since 2008 and underscores FDA's commitment to expediting the development and approval of drugs for patients with serious and life-threatening diseases," said Richard Pazdur, M.D., director, Office of Oncology Drug Products in the FDA's Cente
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 ExeGi Pharma, ... and probiotic treatments, announced today that it has been ... and Non-prescription Health Products Directorate (NNHPD) to sell Visbiome™ ... Visbiome was developed by Professor Claudio De Simone ... extensive clinical investigation. Professor De Simone recently signed an ...
(Date:7/1/2015)... 2015 Boston Scientific Corporation (NYSE: BSX ) ... highlights for the second quarter ended June 30, 2015 on ... The call will be hosted by Mike Mahoney , ... executive vice president and chief financial officer. A ... the Boston Scientific website. Webcast registration is available on the ...
(Date:7/1/2015)... Fla. , July 1, 2015 Rock ... development company focused on chronic inflammatory disease and neurologic ... of principle study with anatabine citrate, the Company,s lead ... oral dose of anatabine citrate can significantly inhibit the ... subjects. The Company is developing this compound in a ...
Breaking Medicine Technology:ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4
(Date:7/1/2015)... ... July 01, 2015 , ... For decades, researchers in the ... remain constant in the brain, never changing after development in the womb. Now, researchers ... steadily replaced in brain cells throughout life – a process which helps to switch ...
(Date:7/1/2015)... PA (PRWEB) , ... July 01, 2015 , ... ... purist natural forms, such as organically raised chickens and eggs. Eating organic foods ... backyard chickens is cleaner and more environmentally friendly than production chicken farming. Choosing ...
(Date:7/1/2015)... ... 01, 2015 , ... OncLive® will team with ... (HCA), as it further expands its Strategic Alliance Partnership Program for raising awareness ... partnership, OncLive’s editorial and marketing teams will collaborate with Sarah Cannon to share ...
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, ... virtual 5K on August 15-16th (MSG Keys’ birthday) in memory of her late husband ... decorated soldier and recipient of the Bronze Star Medal, died during a Special Forces ...
(Date:7/1/2015)... ... July 01, 2015 , ... RowdMap Inc. ... newly released white paper: “Pro-actively Identifying the High-Cost Patient Population: Insights from the ... is available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... Pfizer Inc announced today that its,La Jolla campus will ... staff to cope with San Diego County,s ongoing fire,emergency. ... information from the many agencies involved in dealing with ... impacted by the fires so it,s,important that they take ...
... MAScientists at Schepens Eye Research Institute have discovered a ... other eye disease to keep track of changes in ... weeks PLoS One (October 24, 2007) they demonstrate that ... after-effect (TAE) can accurately identify the location and breadth ...
... of America (PhRMA) President and CEO Billy Tauzin ... "Californians who have been affected by the recent ... should know that help getting the,medicines they need ... The PPA, sponsored by America,s pharmaceutical,research companies, is ...
... Have a Grab ,n Go Bag for each person in ... you need to evacuate, grab your bag,and go. Adult -- ... -- Keys (house and car) -- Money (coins and bills) ... smoke -- Glasses, contacts lenses and solutions -- Medications (at ...
... (VA) continues to offer medical care and other important,services ... Southern,California., "We are grateful no VA facilities have ... Affairs Gordon H. Mansfield.,"Our first priority is the safety ... VA Medical Center and clinics remain open for all ...
... Couples with troubled relationships have hardening of the coronary arteries, ... When married couples lose their cool with one another, it ... found. , What,s more, the damage that,s wrought may ... study leader Tim Smith, a professor of psychology at the ...
Cached Medicine News:Health News: 'Twinkle after effect' can help retinal patients detect vision loss quickly and cheaply 2Health News: 'Twinkle after effect' can help retinal patients detect vision loss quickly and cheaply 3Health News:Help for California Fire Evacuees Possible Through Partnership for Prescription Assistance 2Health News:Grab 'n Go Bags 2Health News:Marital Stress Linked to Heart Disease 2Health News:Marital Stress Linked to Heart Disease 3
The new ProteomeX Workstation enables the rapid set up, execution and analysis of multidimensional LC/MS methods, providing you with the best possible technique to characterize your complex proteomic...
... over a wide range of concentration, ... more thorough characterization than other methods. ... relative change in the distribution of ... to measure heterogeneity, stoichiometry and self-associating ...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint, reaction is complete in five minutes at 37C. Wavelength: 540 nm. Linearity: 1000 mg/dL (11.3 mmol/...
Medicine Products: